Scinai Immunotherapeutics Ltd.
199.4M
$0.97M
-0.20
$-3.56
No price alerts set. Add an alert to get notified!
-0.20
0.21
$-3.56
-102.52%
-633.64%
-575.29%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
AZTR
Azitra, Inc.
|
$0.22 | 3.33% | -0.10 | $2.36M | 0.16 |
|
ENVB
Enveric Biosciences, Inc.
|
$5.04 | 25.37% | -0.61 | $3.01M | 0.00 |
|
INDP
Indaptus Therapeutics, Inc.
|
$3.30 | 4.76% | -0.34 | $5.78M | 0.00 |
|
JSPR
Jasper Therapeutics, Inc.
|
$0.84 | -7.37% | -0.21 | $13.63M | 0.30 |
|
ONCO
Onconetix, Inc.
|
$0.59 | -11.84% | -0.14 | $2.01M | 0.00 |
|
PBM
Psyence Biomedical Ltd.
|
$7.91 | -12.40% | 4.44 | $150,440 | 0.00 |
|
REVB
Revelation Biosciences, Inc.
|
$1.17 | 0.00 | -0.08 | $4.35M | 0.08 |
|
SLRX
Salarius Pharmaceuticals, Inc.
|
$0.84 | 29.23% | -0.21 | $4.92M | 0.00 |
|
SLXN
Silexion Therapeutics Ltd.
|
$0.78 | -14.90% | -0.21 | $439,235 | 0.18 |
|
SPRC
SciSparc Ltd.
|
$6.69 | 1.67% | -0.03 | $386,943 | -3.14 |
* Peer stocks are selected based on market capitalization and sector
$6.18
$0.46
$0.00
0.00%
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
